India to Singapore: Neosporin Export Trade Route
India has recorded 63 verified shipments of Neosporin exported to Singapore, representing a combined trade value of $2.4K USD. This corridor is served by 9 active Indian exporters, with an average shipment value of $38 USD. The leading Indian exporter is TULSI MEDICAL & GENERAL STORES , which accounts for 23% of total export value with 21 shipments worth $545 USD. On the buying side, TO THE ORDER OF INVOICE RAISED TO is the largest importer in Singapore with $387 USD in purchases. The top 3 suppliers — TULSI MEDICAL & GENERAL STORES , N CHIMANLAL ENTERPRISES, SHREE SSD PHARMA PRIVATE LIMITED — together control 54% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Singapore Neosporin corridor is one of India's established pharmaceutical export routes, with 63 shipments documented worth a combined $2.4K USD. The route is dominated by TULSI MEDICAL & GENERAL STORES , which alone accounts for roughly 23% of all export value, reflecting the consolidated nature of India's neosporin manufacturing sector.
Across 9 active suppliers, the average shipment value stands at $38 USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (60%) and air (40%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during April-June, with an average transit time of 9 days port-to-port. The route has recorded an annual growth rate of 5%, placing it at rank #5 among India's top neosporin export destinations globally.
On the import side, key buyers of Indian neosporin in Singapore include TO THE ORDER OF INVOICE RAISED TO, ALSTERN MARINE OFFSHORE PT LIMITED, THE MANAGER and 24 others. TO THE ORDER OF INVOICE RAISED TO is the single largest importer with 1 shipments valued at $387 USD.
